VIRECAPS2: Impact of Virtual Reality on the Mental Health of Patients Undergoing Adjuvant Treatment for Colorectal Cancer
Study Details
Study Description
Brief Summary
The increase in the survival of cancer patients and the incidence of cancers leads to a rapid increase in the number of people living after a diagnosis of cancer.
Occupation during chemotherapy treatment time has been identified as an excellent way to support cancer patients. Studies show that distraction interventions increase tolerance to treatment, by decreasing the importance given to negative stimuli associated with chemotherapy and increasing pleasurable emotions.
In this context, virtual reality (VR) is a promising intervention for patients receiving chemotherapy. VR is considered a powerful painkiller, even more effective than other distractors, such as movies or video games for example.
Several studies have shown short-term beneficial effects of integrating VR in patients undergoing chemotherapy. This intervention would help patients better adhere to and tolerate treatment. Considering that positive emotions could be one of the underlying processes necessary for the effectiveness of VR, it would be possible to support the cancer patient towards better overall well-being thanks to these new technologies.
Investigators can therefore ask themselves the question of the impact that VR used during chemotherapy can have on the adaptation of patients to the disease and its treatments as well as on their psychological distress in the medium and long term.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
The increase in the survival of cancer patients and the incidence of cancers leads to a rapid increase in the number of people living after a diagnosis of cancer. Supporting people during and after treatment is an element of the third Cancer Plan (2014-2019) promoting the emergence of innovations for the benefit of patients as well as the implementation of global and personalized actions of support, and wishing to reduce the impact of cancer on personal life.
Occupation during chemotherapy treatment time has been identified as an excellent way to support cancer patients. Studies show that distraction interventions (progressive relaxation, guided imagery, cognitive distractions such as reading, humor, listening to music, watching a movie, etc.) increase tolerance to treatment, by decreasing the importance given to negative stimuli associated with chemotherapy and increasing pleasurable emotions.
In this context, virtual reality (VR) is a promising intervention for patients receiving chemotherapy. It makes it possible to modulate the attentional and emotional processes responsible for physiological and psychic reactions (pain, psychological distress, anxiety). VR is considered a powerful painkiller, even more effective than other distractors, such as movies or video games for example.
Several studies have shown short-term beneficial effects of integrating VR in patients undergoing chemotherapy. This intervention would help patients better adhere to and tolerate treatment. Considering that positive emotions could be one of the underlying processes necessary for the effectiveness of VR, it would be possible to support the cancer patient towards better overall well-being thanks to these new technologies.
Investigators can therefore ask themselves the question of the impact that VR used during chemotherapy can have on the adaptation of patients to the disease and its treatments as well as on their psychological distress in the medium and long term.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Active Comparator: Standard time occupation of treatment period habitual distraction of patients during chemotherapy sessions authorized as part of routine care (doing nothing, discussion, reading, games, etc.). |
Behavioral: Standard distraction during chemotherapy treatment period
habitual distraction of patients during chemotherapy sessions authorized as part of routine care
|
| Experimental: time occupation of treatment period by virtual reality Use of virtual reality as a distraction during chemotherapy sessions. A virtual reality headset will be worn for 15 minutes per hour of treatment (with a maximum of three sessions per cycle of chemotherapy) |
Behavioral: Virtual distraction during chemotherapy treatment period
A virtual reality headset will be worn for 15 minutes per hour of treatment
|
Outcome Measures
Primary Outcome Measures
- Level of psychological well-being [6 months]
Total score from WEMWBS scale
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Male or female, over 18 years of age.
-
Patient with colorectal cancer treated with adjuvant chemotherapy.
-
Chemotherapy naïve patient
-
Patient speaking and understanding French and able to complete the questionnaires.
-
Affiliated patient or beneficiary of a social security scheme.
-
Patient having been informed of the research and having signed a free and informed consent
Exclusion Criteria:
-
Patient participating in another clinical study
-
Patient with a history or progressive psychiatric illness
-
Patient with severe visual and hearing impairment
-
Patient not supporting the wearing of the virtual reality headset
-
Patient who is unable to undergo medical monitoring for geographical, social or psychological reasons
-
Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision
-
Pregnant, breastfeeding or parturient women
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Hôpital Privé Drôme Ardèche | Guilherand-Granges | Aura | France | 07500 |
Sponsors and Collaborators
- Ramsay Générale de Santé
- GCS Ramsay Santé pour l'Enseignement et la Recherche
Investigators
- Principal Investigator: Sophie Lantheaume, Dr, Ramsay Santé - Hôpital Privé Drôme
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2021-A02382-39